复旦张江
上海复旦张江生物医药股份有限公司，一九九六年十一月创建于上海浦东张江高科技园区之“张江药谷”，上海医药集团股份有限公司、中国通用技术（集团）控股有限责任公司、张江高科技园区开发股份有限公司和复旦资产经营有限公司等知名企业和大学为公司主要股东。

本着"我们多一分探索，人类多一分健康"的信念，公司主要从事生物医药的创新研究、开发、生产和销售，力求成为一家以知识产权为核心源泉的生物医药创新企业。经过多年的不懈努力，公司在基因工程药物、光动力药物、医学诊断及药物传输系统等领域不断推出新产品，形成了明显的竞争优势，预计未来每年将有一二个新药投放市场。

凭籍在生物医药领域的实力，公司多次担纲国家级研发项目，包括国家重点科技项目计划和国家高技术研究发展计划（八六三计划）等。一九九八年以来，公司被连续认定为“高新技术企业”，一九九九年，公司被国家人事部批准为“企业博士后科研工作站”。二〇〇二年八月，公司在香港创业板成功上市（股票代码：8231）。

公司现控股上海摩根谈国际生命科学中心有限公司、上海靶点药物有限公司及泰州复旦张江药业有限公司，参股上海先导药业有限公司。公司人力资源丰富，技术力量强大，近200名高素质的员工将推动公司不断创新，实现飞跃。

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (FDZJ) was established in Novmber,1996 and located in the “Drug Valley”, Zhangjiang Hi-tech Park, Pudong District, Shanghai. The shareholders include Shanghai Pharmaceuticals Holding Co.,Ltd., Genertech Holding Co., Ltd., Zhangjiang Hi-tech Development Co., Ltd., Fudan University.

With the philosophy of “the more we probe, the healthier the people will be”, aiming at becoming an innovative bio-medical company possessing intellectual properties as the core competitive force, the company deals with new drug R&D as well as production and sales. Many years of the persistent effort have brought many new results in the R&D of genetic engineering drugs, photodynamic drugs, diagnosis reagents and new dosage forms with the improving drug delivery properties and competitive advantage for the company. One or two new drugs will be launched every year since this year.

Owing to the strength of the R&D in bio-pharmaceutical field, the company has played an important role in many national R&D projects, such as national key project of science and technology development and national hi-tech R&D projects. The company has continuously characterized as an Advance Science and Technology Enterprise since 1998, recognized as a Postdoctoral Study Station since 1999 and fulfilled the procedure of IPO listed in Hong Kong GEM since 2002.

The company organized four subsidiary companies: Shanghai Morgan Tan International Centre for Life Science, Taizhou Fudan-Zhangjiang Pharmaceutical Co.,Ltd., Shanghai TargetDrug Pharmaceutical Co.,Ltd. And Shanghai Lead Discovery Pharmaceutical Co., Ltd. Due to the rich brain-source and strong technical source, about 200 staff member well educated and trained will surely create more and push the company go forward rapidly.